Toril Holien

Toril Holien

@torilhol.bsky.social

Prof. Cell & molecular biology. Educating biomedical scientists. Myeloma. TGFbeta. Cell signaling. Cancer. @NTNU & St. Olavs Hospital, Norway 🇳🇴. She/Her 🧪🧬🩸🔬 Orcid: https://orcid.org/my-orcid?orcid=0000-0002-2051-5824

2.2K followers4.9K following136 posts

Toril Holien reposted

I am a long time subscriber to National Geographic. National Geographic generally does a superb job of covering complex scientific topics. However, The End of Aging” in the September issue was a dramatic deviation from this record. 1/n

Toril Holien reposted

Toril Holien reposted

Great to see the Virtual BMP Forum getting in shape for the 3rd round 😊! Organizers Eri Takematsu, David Maridas, Marie Jose Goumans and @jeromejatzlau.bsky.social First topic is mechanobiology and cardiovascular biology Please share and join here 👇!

3rd Virtual BMP Forum@bmpforum.bsky.social

The 3rd Virtual BMP Forum is back! Join us for our next session, featuring exciting presentation on BMP signaling in mechanobiology and cardiovascular biology. September 16 🕘 9:00–10:30 AM EST | 3:00–4:30 PM CET Please register using the QR code or the link below. docs.google.com/forms/d/e/1F...

Toril Holien reposted

Don’t miss 2026 Edward Novitski Prize recipient Michael O’Connor on August 11 to learn how a 30-year quest to understand the shrew gene is shedding new light on Drosophila embryonic development. 🔗https://buff.ly/uvGHncW

Toril Holien reposted

BMP10 KO alone, but not BMP9 KO alone, induces #ArterioVenousMalformation in 🐭Retina Brain wounded Skin ROSA26-CreER; Bmp10 f/f vs Bmp9-/- vs compound KO B6/129 strain Exogenous BMP10, not BMP9, rescues retinal vascularization in BMP9/10 dKO🐭 #Angiogenesis 2023 link.springer.com/article/10.1...

Toril Holien reposted

Toril Holien reposted

Talquetamab–daratumumab, with or without pomalidomide, led to longer progression-free survival than daratumumab-based standard care in relapsed or refractory myeloma. More than 75% of patients had grade 3 or higher adverse events. Full MonumenTAL-3 trial results: https://nej.md/4ojBcCL #EHA2026

Interested in TGF-β family signaling? Then you should join us for the upcoming FASEB conference #TGFbSRC

FASEB@faseborg.bsky.social

For 25+ years #TGFbSRC has united researchers of a critical signaling pathway. This conference gathers academic and industry leaders plus early-career investigators to discuss the latest TGF‑β family signaling. Extended abstract & early registration deadline: June 14.

Still time to register & submit your abstract for a potential short talk! The FASEB TGF-β family in Development and Disease conference in Porto, July 26.-30. coming up. Early registration and extended abstract submission deadline is June 14th 👇 @mythreye.bsky.social events.faseb.org/event/TGF-B/...

events.faseb.orgHome - TGF-β Family in Development and DiseaseJoin leaders in TGF-β signaling to explore breakthroughs in development, disease, and therapy at this premier forum for basic and translational research.

Toril Holien reposted

Earlier this week I posted an example of a fake western blot provided by ThermoFisher to demonstrate the validity of a p53 antibody. I considered it an amusing curiosity. In fact Thermo Fisher Scientific has systematically manipulated antibody validation data!

Toril Holien reposted

Great review on MGUS!

Vincent Rajkumar, MD@vincentrk.bsky.social

Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM 5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. www.nejm.org/doi/abs/10.1...

Join us for the FASEB Science Research conference on TGF-β Family in Development and Disease! Awards Abstract Submission Deadline: April 15, 2026. @faseborg.bsky.social @mythreye.bsky.social

Toril Holien@torilhol.bsky.social

Registration is open 😀! Make a note of these dates: Awards Abstract Submission Deadline: April 15, 2026 Regular Abstract Submission Deadline: May 31, 2026 Early Registration Deadline: June 14, 2026 events.faseb.org/event/TGF-B/...

Toril Holien reposted

Check out the global speaker line up. several travel awards and slots for short talks open. Don’t miss this summer @faseborg.bsky.social events.faseb.org/event/TGF-B/...

events.faseb.orgTGF-β Family in Development and Disease.Join leaders in TGF-β signaling to explore breakthroughs in development, disease, and therapy at this premier forum for basic and translational research.
Toril Holien@torilhol.bsky.social

📣 Save the date 📣 The next FASEB Science Research Conference on TGF-β Family in Development and Disease will take place: July 26-30, 2026 in Porto, Portugal! @faseborg.bsky.social With Mythreye Karthikeyan @mythreye.bsky.social, Rosemary Akhurst and Andrew Hinck web.cvent.com/event/af5f6d...

Toril Holien reposted

Discovery and Characterization of Zilurgisertib, a Potent and Selective Inhibitor of Activin Receptor-like Kinase‑2(ALK2) for the Treatment of Fibrodysplasia Ossificans Progressiva. T Ullrichet al. ACSMed.Chem. Lett. 31Oct 2025 shorturl.at/UCzDT …mouse model …start clinical trial

Toril Holien reposted

Toril Holien reposted

C'mon guys. Cells show blebbing and death was inhibited by caspase inhibitors and had mitochondrial permeabilization. In my alternate universe, this is apoptosis 🙄

Our preprint is out! We induced apoptosis in myeloma cells with BMP9 and did a whole genome KO screen to find regulators of apoptosis (and BMP-SMAD signaling). ID3 induced by SMAD activity inhibited TCF3 and induced apoptosis. This was the main work in Clara Andersson-Rusch's PhD. Have a look! 👇

bioRxiv Cancer Bio@biorxiv-cancer.bsky.social

Whole genome CRISPR knockout screen reveals ID3 as a key regulator of myeloma cell survival via TCF3 and c-MYC https://www.biorxiv.org/content/10.1101/2025.09.09.675036v1

Toril Holien reposted

Elskar når folk som ikkje anar noko om landbruk skal romantisere denne livsstilen, og så lage tv av at dei ikkje er førebudd på det betyr å vere bonde. Då blir det rør. Heggdal er god til å rydde opp.

Krister Hoaas@krhoaas.eurosky.social

Øystein Heggdal med voksenopplæring til Jon Almaas og drømmerier om at økologisk jordbruk er bedre for klode og mennesker www.nrk.no/ytring/jon-b...

Toril Holien reposted

Ever wondered what happens when therapeutic antibodies bind to cancer cells? In our latest study, we used multiplexed 3D-RESI to directly visualize how anti-CD20 antibodies interact with their receptors, revealing their precise arrangement at single-protein resolution. (1/6)

Toril Holien reposted

Translational research is digging for gold. Basic research is learning where and what to dig. The more funding is diverted to translation, the more we deplete the research ecosystem, driving the supplies of "gold" - immediately translatable findings and innovations - to unsustainably low levels.

Toril Holien reposted

I still can’t believe that all NIH grants to my colleagues at Harvard and Harvard Medical School have been nullified. And that, as a nation, we’re somehow okay with this illegal, arbitrary, and petty act. Just think of the consequences: scientists, students, and patients will all suffer.